Cargando…
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
BACKGROUND: Prophylactic cotrimoxazole treatment is recommended in human immunodeficiency virus (HIV)–exposed, uninfected (HEU) infants, but the effects of this treatment on developing HEU infant gut microbiotas and resistomes are largely undefined. METHODS: We analyzed whole-metagenome sequencing d...
Autores principales: | D’Souza, Alaric W, Moodley-Govender, Eshia, Berla, Bertram, Kelkar, Tejas, Wang, Bin, Sun, Xiaoqing, Daniels, Brodie, Coutsoudis, Anna, Trehan, Indi, Dantas, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778358/ https://www.ncbi.nlm.nih.gov/pubmed/31832638 http://dx.doi.org/10.1093/cid/ciz1186 |
Ejemplares similares
-
Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol
por: Coutsoudis, Anna, et al.
Publicado: (2016) -
Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013) -
Differential Effects of Azithromycin, Doxycycline, and Cotrimoxazole in Ingested Blood on the Vectorial Capacity of Malaria Mosquitoes
por: Gendrin, Mathilde, et al.
Publicado: (2016) -
Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013) -
Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children
por: Longwe, Herbert, et al.
Publicado: (2015)